Gravol and Gliclazide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Gravol (dimenhydrinate) and Gliclazide (gliclazide). Common drug interactions include back pain among females and cardiac failure congestive among males.
The phase IV clinical study analyzes what interactions people have when they take Gravol and Gliclazide. It is created by eHealthMe based on reports of 134 people who take the same drugs from the FDA, and is updated regularly.
What is Gravol?
Gravol has active ingredients of dimenhydrinate. It is often used in nausea. eHealthMe is studying from 7,192 Gravol users. Check the latest studies of Gravol.
What is Gliclazide?
Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
134 people who take Gravol and Gliclazide together, and have interactions are studied.
What are the common drug interactions of Gravol and Gliclazide, by gender? *
What are the common drug interactions of Gravol and Gliclazide, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Gravol and Gliclazide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Gravol (7,192 reports)
- Gliclazide (28,131 reports)
Browse all drug interactions of Gravol and Gliclazide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Gravol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Gliclazide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Gravol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Gliclazide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on dimenhydrinate and gliclazide (the active ingredients of Gravol and Gliclazide, respectively), and Gravol and Gliclazide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Respiratory Syncytial Virus Infection and drugs of ingredients of fexofenadine hydrochloride - 6 seconds ago
- Could Vx-950 cause Memory Loss? - 6 seconds ago
- Increased Upper Airway Secretion and drugs of ingredients of denosumab - 7 seconds ago
- Drug interactions of Mefenamic Acid and Leuprolide Acetate - 7 seconds ago
- Device Dislocation and drugs of ingredients of fentanyl citrate - 8 seconds ago
- Unevaluable Reaction and drugs of ingredients of hydrochlorothiazide - 9 seconds ago
- Pyridium vs. Amoxicillin, side effect and effectiveness comparison - 10 seconds ago
- Submandibular Mass and drugs of ingredients of dexamethasone - 13 seconds ago
- Escitalopram Oxalate and Urinary Tract Infection for Men aged 60+ - 14 seconds ago
- Escitalopram Oxalate and Uti for Men aged 60+ - 15 seconds ago